Page last updated: 2024-10-29

iohexol and Liver Steatosis

iohexol has been researched along with Liver Steatosis in 2 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, DY1
Park, SH1
Lee, SS1
Kim, HJ1
Kim, SY1
Kim, MY1
Lee, Y1
Kim, TK1
Khalili, K1
Bae, MH1
Lee, JY1
Lee, SG1
Yu, ES1
Koseoglu, K1
Ozsunar, Y1
Taskin, F1
Karaman, C1

Other Studies

2 other studies available for iohexol and Liver Steatosis

ArticleYear
Contrast-enhanced computed tomography for the diagnosis of fatty liver: prospective study with same-day biopsy used as the reference standard.
    European radiology, 2010, Volume: 20, Issue:2

    Topics: Adult; Biopsy; Contrast Media; Fatty Liver; Female; Humans; Iohexol; Male; Radiographic Image Enhanc

2010
Pseudolesions of left liver lobe during helical CT examinations: prevalence and comparison between unenhanced and biphasic CT findings.
    European journal of radiology, 2005, Volume: 54, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Fatty Liver; Female; Humans

2005